Xenon Pharmaceuticals Inc (XENE)

Operating Expenses

$363.92M

TTM · Period ending: · USD

XENE logo

XENE Operating Expenses

Latest reported$363.92M
XENE TTM Operating Expenses ($12.78M → $363.92M)
High-resolution chart · PNG

XENE operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Xenon Pharmaceuticals Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
363,921,000
334,363,000
302,273,000
270,594,000
324,988,000
300,495,000
278,699,000
254,917,000
236,925,000
223,445,000
214,054,000
203,690,000
156,835,000
109,916,000
67,640,000
30,997,000
26,999,000
24,633,000
21,967,000
18,385,000
29,807,000
37,498,000
48,500,000
60,321,000
56,519,000
53,001,000
49,648,000
43,155,000
38,882,000
35,956,000
32,016,000
31,649,000
32,379,000
32,701,000
32,886,000
30,657,000
29,493,000
28,364,000
26,620,000
26,612,000
23,982,000
21,050,000
20,007,000
19,020,000
18,438,000
18,511,000
17,264,000
15,985,000
15,722,000
14,277,499
12,783,998
11,642,498
9,795,998
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.